BIOTECHNOLOGY VALUE FUND
Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments. BVF is committed to working with its portfolio companies as partners in their successes.
BIOTECHNOLOGY VALUE FUND
Industry:
Biotechnology Venture Capital
Founded:
1993-01-01
Status:
Active
Contact:
(312)506-6479
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress PHP PHP 7 Twemoji OpenResty
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Azure Capital Partners
Azure Capital Partners is a venture capital firm specializing in early-stage and growth capital investments.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Matthew Perry Portfolio Manager @ Biotechnology Value Fund
Portfolio Manager
1996-12-01
Gorjan Hrustanovic Managing Director @ Biotechnology Value Fund
Managing Director
2020-12-01
Spike Loy Managing Director @ Biotechnology Value Fund
Managing Director
2009-09-01
Sam Huang Principal @ Biotechnology Value Fund
Principal
2018-07-01
Michael Murray Analyst @ Biotechnology Value Fund
Analyst
Kanishka Pothula Managing Director @ Biotechnology Value Fund
Managing Director
2012-03-01
Mitchell Kaye Business & Operations @ Biotechnology Value Fund
Business & Operations
2013-09-01
James Kratky Chief Financial Officer, Chief Compliance Officer @ Biotechnology Value Fund
Chief Financial Officer, Chief Compliance Officer
2017-05-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-19 | Kymera Therapeutics | Biotechnology Value Fund investment in Post-IPO Equity - Kymera Therapeutics | 150 M USD |
| 2021-07-13 | Nimbus Therapeutics | Biotechnology Value Fund investment in Venture Round - Nimbus Therapeutics | 105 M USD |
| 2021-04-08 | Ventus Therapeutics | Biotechnology Value Fund investment in Series B - Ventus Therapeutics | 100 M USD |
| 2021-03-30 | Pyxis Oncology | Biotechnology Value Fund investment in Series B - Pyxis Oncology | 152 M USD |
| 2020-12-28 | Gritstone Bio | Biotechnology Value Fund investment in Post-IPO Equity - Gritstone Bio | 125 M USD |
| 2020-07-22 | Olema Oncology | Biotechnology Value Fund investment in Series B - Olema Oncology | 54 M USD |
| 2020-06-11 | Autobahn Therapeutics | Biotechnology Value Fund investment in Series B - Autobahn Therapeutics | 76 M USD |
| 2020-05-20 | Surface Oncology | Biotechnology Value Fund investment in Post-IPO Equity - Surface Oncology | 28.9 M USD |
| 2020-03-12 | Kymera Therapeutics | Biotechnology Value Fund investment in Series C - Kymera Therapeutics | 102 M USD |
| 2020-01-31 | Syndax Pharmaceuticals | Biotechnology Value Fund investment in Post-IPO Debt - Syndax Pharmaceuticals | 30 M USD |
More informations about "Biotechnology Value Fund"
BIOTECHNOLOGY VALUE FUND L P - WhaleWisdom.com
46 rows Biotechnology Value Fund L P is based out of San Francisco. Whalewisdom has at …See details»
Biotechnology Value Fund - Investments, Portfolio & Company Exits
Biotechnology Value Fund has made 28 diversity investments. Their most recent diversity investment was on Dec 23, 2024, when Ikena Oncology raised. obfuscated. obfuscated. …See details»
Hedge Fund - Biotechnology Value Fund / BVF Inc - Insider Monkey
Jul 24, 2017 Established in 1993, Biotechnology Value Fund is a private investment partnership headquartered in San Francisco. Specializing in fundamentally driven public biotechnology …See details»
Biotechnology Value Fund: Performance - PitchBook
Jan 9, 2008 Biotechnology Value Fund General Information Description. Biotechnology Value Fund is an equity hedge fund managed by BVF Partners. The fund is located in San …See details»
Biotechnology Value Fund Portfolio Companies - Crunchbase
Nov 10, 2011 Biotechnology Value Fund is an evergreen fund specializing in early stage financing. It focuses on undervalued investment. This list of organizations invested in by …See details»
Biotechnology Value Fund - Massinvestor Venture Capital and …
Biotechnology Value Fund (BVF Partners) is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its …See details»
Biotechnology Value Fund - Investor in San Francisco, California
Biotechnology Value Fund Partners L.P. is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. BFV has strived to build …See details»
Biotechnology Value Fund (BVF Partners) - Golden
BVF Partners L.P. is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, …See details»
Biotechnology Value Fund - SPEEDA Edge
Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has …See details»
Biotechnology Value Fund - vcinvestorlist.com
Biotechnology Value Fund is an evergreen fund specializing in early stage financing. It focuses on undervalued investment Number of Investments: 153 Number of Exits: 81 Investment …See details»
Biotechnology Value Fund L P - CapEdge
Biotechnology Value Fund L P 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 Phone. 3125066500. Ownership. Fund structure AUM Fund type; BVF Partners L.P. …See details»
Biotechnology Value Fund LP - AUM 13F
Fund Details; Director: BVF I GP LLC, BVF Partners LP: Custodian: The Bank of New York Mellon, Jefferies LLC: Auditor: PriceWaterhouseCoopers LLP, Pricewaterhouse CoopersSee details»
Biotechnology Value Fund – Investors Database – Unicorn Nest
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Biotechnology Value Fund, startups are often financed by Third Rock Ventures, The Column Group, Celgene. …See details»
Biotechnology Value Fund II: Performance - PitchBook
Dec 10, 2021 Biotechnology Value Fund II is a fundamental equity hedge fund managed by BVF Partners. The fund is located in San Francisco, California. The fund prefers to invest in …See details»
Biotechnology Value Fund L P Portfolio Holdings - Fintel
May 30, 2024 BIOTECHNOLOGY VALUE FUND L P: Portfolio Value: $ 1,930,323,047: Current Positions: 50: Activist Positions: 18: Latest Holdings, Performance, AUM (from 13F, 13D) Add …See details»
Biotechnology Value Fund L P Now Owns 5.10% of Ideaya
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 2.46MM shares of Ideaya Biosciences Inc . This represents 5.1% of the …See details»
Biotechnology Value Fund II LP - AUM 13F
Fund Details; Director: BVF II GP LLC, BVF Partners LP: Custodian: The Bank of New York Mellon, Jefferies LLC: Auditor: PriceWaterhouseCoopers LLP, Pricewaterhouse CoopersSee details»
Biotechnology Value Fund - Contacts, Employees, Board
Biotechnology Value Fund has 8 current employee profiles, including Portfolio Manager Matthew Perry. Matthew Perry Portfolio Manager. Mark Nathan Lampert President, CEO/Founder. …See details»
Biotechnology Value Fund L P Now Owns 9.60% of Protagonist
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 5.03MM shares of Protagonist Therapeutics Inc ().This represents 9.6% of the …See details»
Regal’s listed funds slash value of biotech Opthea by two-thirds
15 hours ago The high-profile hedge fund run by veteran stockpicker Phil King has slashed the value of its stake in Opthea by two-thirds after the eye treatment biotech said it faced collapse …See details»